Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
2017; Elsevier BV; Volume: 147; Issue: 2 Linguagem: Inglês
10.1016/j.ygyno.2017.08.015
ISSN1095-6859
AutoresLainie P. Martin, Jason Konner, Kathleen N. Moore, Shelly Seward, Ursula A. Matulonis, Raymond P. Perez, Ying Su, Anna Berkenblit, Rodrigo Ruiz-Soto, Michael J. Birrer,
Tópico(s)Lymphoma Diagnosis and Treatment
ResumoTo characterize folate receptor alpha (FRα) expression in archival and fresh biopsy tumor samples from relapsed ovarian cancer patients.
Referência(s)